The American Thyroid Association and the European Thyroid Association, invite you to join a webinar on Wednesday, January 18, 2023 at 12pm EST (NY)/17:00 (London)/18:00 (Brussels), to hear highlights from the document "Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and European Thyroid Association".
The consensus statement was drafted by a multidisciplinary, global writing task force led by co-chairs from both societies, including Henry B. Burch, MD, Program Director, Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and Petros Perros, MD, Honorary Consultant in Endocrinology at Newcastle upon Tyne Hospitals NHS Foundation Trust. The final document integrates feedback from patients and the ophthalmology community, comments from ATA and ETA members, and it underwent formal peer-review in Thyroid and the European Thyroid Journal. Potential conflict of interest was managed, and transparency maintained in formulating the consensus statement. The consensus statement, prepared as a clinical resource for endocrinologists, is available online and has been co-published in the peer-reviewed journals Thyroid® and the European Thyroid Journal
Faculty: Henry B. Burch, MD; Ilse Mombaerts, MD; Angela Leung, MD, MSc; Mario Salvi, MD; Petros Perros, MD; Marius Stan, MD
Virtual Meeting Code of Conduct & Social Media Policy - All registered attendees are asked to review and agree to the ATA Virtual Meeting Code of Conduct and Social Media Policy.
Media Policy - All registered media attendees are asked to review and agree to the ATA Press/Media Registration and Policy for Virtual Events.
The time listed below is on January 18, 2023 in EST. The webinar times are converted for the following cities:
12:00 New York
01:00 Hong Kong